×
Sanofi Revenue 2010-2024 | SNY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sanofi revenue for the twelve months ending December 31, 2024 was
$47.922B
, a
4.66% decline
year-over-year.
Sanofi annual revenue for 2024 was
$47.922B
, a
4.66% decline
from 2023.
Sanofi annual revenue for 2023 was
$50.266B
, a
5.11% increase
from 2022.
Sanofi annual revenue for 2022 was
$47.822B
, a
3.18% increase
from 2021.
View More
Sanofi Revenue 2010-2024 | SNY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sanofi annual revenue for 2024 was
$47.922B
, a
4.66% decline
from 2023.
Sanofi annual revenue for 2023 was
$50.266B
, a
5.11% increase
from 2022.
Sanofi annual revenue for 2022 was
$47.822B
, a
3.18% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$823.1B
Johnson & Johnson (JNJ)
$380.1B
Novo Nordisk (NVO)
$374.3B
AbbVie (ABBV)
$348.4B
Roche Holding AG (RHHBY)
$259.5B
Novartis AG (NVS)
$218.5B
Merck (MRK)
$216.5B
Pfizer (PFE)
$146.7B
Bayer (BAYRY)
$22B
Innoviva (INVA)
$1.1B